FDC
Back to Income Statement
|
FDC Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,171 Cr | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr |
What is the latest Revenue of FDC ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,171 Cr |
| Mar2025 | ₹2,108 Cr |
| Mar2024 | ₹1,943 Cr |
| Mar2023 | ₹1,784 Cr |
| Mar2022 | ₹1,528 Cr |
How is Revenue of FDC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,171 Cr | 2.98 | |
| Mar2025 | ₹2,108 Cr | 8.50 | |
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | - | |
Compare Revenue of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,400.5 Cr | 0.9% | 19.5% | -12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 0.9% |
19.5% |
-12.3% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses